The κ-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons

Bassil Hassan, Victor Ruiz-Velasco

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background and Objectives: κ-Opioid receptor (κ-OR) activation is known to play a role in analgesia and central sedation. The purpose of the present study was to examine the effect of the κ-OR agonist, U-50488 (an arylacetamide), on Ca2+ channel currents and the signaling proteins involved in acutely isolated rat dorsal root ganglion (DRG) neurons expressing the putative promoter region of the tetrodotoxin-resistant Na+ channel (NaV 1.8) that is known to be involved in pain transmission. Methods: Acutely isolated rat DRG neurons were transfected with cDNA coding for enhanced green fluorescent protein (EGFP), whose expression is driven by the NaV 1.8 promoter region. Thereafter, the whole-cell variant of the patch-clamp technique was used to record Ca2+ channel currents in neurons expressing EGFP. Results: Exposure of EGFP-expressing DRG neurons to U-50488 (0.3-40 μM) led to voltage-independent inhibition of the Ca2+ channel currents. The modulation of the Ca2+ currents did not appear to be mediated by the Gα protein subfamilies: Gαi/o, Gαs, Gαq/11, Gα14, and Gαz. Furthermore, dialysis of the hydrolysis-resistant GDP analog, GDP-β-S (1 mM), did not affect the U-50488-mediated blocking effect, ruling out involvement of other G protein subunits. Finally, U-50488 (20 μM) blocked Ca 2+ channels heterologously expressed in HeLa cells that do not express κ-OR. Conclusion: These results suggest that the antinociceptive actions mediated by U-50488 are likely due to both a direct block of Ca 2+ channels in sensory neurons as well as G protein modulation of Ca2+ currents via κ-OR-expressing neurons.

Original languageEnglish (US)
Pages (from-to)21-27
Number of pages7
JournalRegional Anesthesia and Pain Medicine
Volume38
Issue number1
DOIs
StatePublished - Jan 1 2013

Fingerprint

(trans)-Isomer 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide
Opioid Receptors
Sensory Receptor Cells
GTP-Binding Proteins
Neurons
Spinal Ganglia
Genetic Promoter Regions
Tetrodotoxin
Protein Subunits
Patch-Clamp Techniques
HeLa Cells
Analgesia
Dialysis
Hydrolysis
Complementary DNA
Pain
enhanced green fluorescent protein
Proteins

All Science Journal Classification (ASJC) codes

  • Anesthesiology and Pain Medicine

Cite this

@article{b4213e46f21844568dfcfb01ccb24eb6,
title = "The κ-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons",
abstract = "Background and Objectives: κ-Opioid receptor (κ-OR) activation is known to play a role in analgesia and central sedation. The purpose of the present study was to examine the effect of the κ-OR agonist, U-50488 (an arylacetamide), on Ca2+ channel currents and the signaling proteins involved in acutely isolated rat dorsal root ganglion (DRG) neurons expressing the putative promoter region of the tetrodotoxin-resistant Na+ channel (NaV 1.8) that is known to be involved in pain transmission. Methods: Acutely isolated rat DRG neurons were transfected with cDNA coding for enhanced green fluorescent protein (EGFP), whose expression is driven by the NaV 1.8 promoter region. Thereafter, the whole-cell variant of the patch-clamp technique was used to record Ca2+ channel currents in neurons expressing EGFP. Results: Exposure of EGFP-expressing DRG neurons to U-50488 (0.3-40 μM) led to voltage-independent inhibition of the Ca2+ channel currents. The modulation of the Ca2+ currents did not appear to be mediated by the Gα protein subfamilies: Gαi/o, Gαs, Gαq/11, Gα14, and Gαz. Furthermore, dialysis of the hydrolysis-resistant GDP analog, GDP-β-S (1 mM), did not affect the U-50488-mediated blocking effect, ruling out involvement of other G protein subunits. Finally, U-50488 (20 μM) blocked Ca 2+ channels heterologously expressed in HeLa cells that do not express κ-OR. Conclusion: These results suggest that the antinociceptive actions mediated by U-50488 are likely due to both a direct block of Ca 2+ channels in sensory neurons as well as G protein modulation of Ca2+ currents via κ-OR-expressing neurons.",
author = "Bassil Hassan and Victor Ruiz-Velasco",
year = "2013",
month = "1",
day = "1",
doi = "10.1097/AAP.0b013e318274a8a1",
language = "English (US)",
volume = "38",
pages = "21--27",
journal = "Regional Anesthesia and Pain Medicine",
issn = "1098-7339",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - The κ-opioid receptor agonist U-50488 blocks Ca2+ channels in a voltage- and G protein-independent manner in sensory neurons

AU - Hassan, Bassil

AU - Ruiz-Velasco, Victor

PY - 2013/1/1

Y1 - 2013/1/1

N2 - Background and Objectives: κ-Opioid receptor (κ-OR) activation is known to play a role in analgesia and central sedation. The purpose of the present study was to examine the effect of the κ-OR agonist, U-50488 (an arylacetamide), on Ca2+ channel currents and the signaling proteins involved in acutely isolated rat dorsal root ganglion (DRG) neurons expressing the putative promoter region of the tetrodotoxin-resistant Na+ channel (NaV 1.8) that is known to be involved in pain transmission. Methods: Acutely isolated rat DRG neurons were transfected with cDNA coding for enhanced green fluorescent protein (EGFP), whose expression is driven by the NaV 1.8 promoter region. Thereafter, the whole-cell variant of the patch-clamp technique was used to record Ca2+ channel currents in neurons expressing EGFP. Results: Exposure of EGFP-expressing DRG neurons to U-50488 (0.3-40 μM) led to voltage-independent inhibition of the Ca2+ channel currents. The modulation of the Ca2+ currents did not appear to be mediated by the Gα protein subfamilies: Gαi/o, Gαs, Gαq/11, Gα14, and Gαz. Furthermore, dialysis of the hydrolysis-resistant GDP analog, GDP-β-S (1 mM), did not affect the U-50488-mediated blocking effect, ruling out involvement of other G protein subunits. Finally, U-50488 (20 μM) blocked Ca 2+ channels heterologously expressed in HeLa cells that do not express κ-OR. Conclusion: These results suggest that the antinociceptive actions mediated by U-50488 are likely due to both a direct block of Ca 2+ channels in sensory neurons as well as G protein modulation of Ca2+ currents via κ-OR-expressing neurons.

AB - Background and Objectives: κ-Opioid receptor (κ-OR) activation is known to play a role in analgesia and central sedation. The purpose of the present study was to examine the effect of the κ-OR agonist, U-50488 (an arylacetamide), on Ca2+ channel currents and the signaling proteins involved in acutely isolated rat dorsal root ganglion (DRG) neurons expressing the putative promoter region of the tetrodotoxin-resistant Na+ channel (NaV 1.8) that is known to be involved in pain transmission. Methods: Acutely isolated rat DRG neurons were transfected with cDNA coding for enhanced green fluorescent protein (EGFP), whose expression is driven by the NaV 1.8 promoter region. Thereafter, the whole-cell variant of the patch-clamp technique was used to record Ca2+ channel currents in neurons expressing EGFP. Results: Exposure of EGFP-expressing DRG neurons to U-50488 (0.3-40 μM) led to voltage-independent inhibition of the Ca2+ channel currents. The modulation of the Ca2+ currents did not appear to be mediated by the Gα protein subfamilies: Gαi/o, Gαs, Gαq/11, Gα14, and Gαz. Furthermore, dialysis of the hydrolysis-resistant GDP analog, GDP-β-S (1 mM), did not affect the U-50488-mediated blocking effect, ruling out involvement of other G protein subunits. Finally, U-50488 (20 μM) blocked Ca 2+ channels heterologously expressed in HeLa cells that do not express κ-OR. Conclusion: These results suggest that the antinociceptive actions mediated by U-50488 are likely due to both a direct block of Ca 2+ channels in sensory neurons as well as G protein modulation of Ca2+ currents via κ-OR-expressing neurons.

UR - http://www.scopus.com/inward/record.url?scp=84872064748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84872064748&partnerID=8YFLogxK

U2 - 10.1097/AAP.0b013e318274a8a1

DO - 10.1097/AAP.0b013e318274a8a1

M3 - Article

C2 - 23222359

AN - SCOPUS:84872064748

VL - 38

SP - 21

EP - 27

JO - Regional Anesthesia and Pain Medicine

JF - Regional Anesthesia and Pain Medicine

SN - 1098-7339

IS - 1

ER -